Cahill Brian Joseph Insider Trades

Insider Trading History

Track insider trading activity for Cahill Brian Joseph. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
CHIEF FINANCIAL OFFICER
Holding Value $26k 49,547 shares
Last Trade
Feb 27, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$24.5k 3,800 shares
$6.44
$0.52
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
CHIEF FINANCIAL OFFICER
Holding Value $25.2k 47,958 shares
Last Trade
Feb 27, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$10.2k 1,589 shares
$6.44
$0.52
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
CHIEF FINANCIAL OFFICER
Holding Value $24k 45,747 shares
Last Trade
Feb 02, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$5.46k 934 shares
$5.85
$0.52
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Chief Financial Officer
Holding Value $24.5k 46,681 shares
Last Trade
Jan 05, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.77k 735 shares
$5.13
$0.52
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Chief Financial Officer
Holding Value $24.9k 47,416 shares
Last Trade
Dec 18, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.15k 452 shares
$4.76
$0.52
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Chief Financial Officer
Holding Value $25.1k 47,868 shares
Last Trade
Mar 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$514k 18,500 shares
$27.81
$0.52
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Chief Financial Officer
Holding Value $15.4k 29,368 shares
Last Trade
Feb 28, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$20.1k 718 shares
$28.00
$0.52
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Chief Financial Officer
Holding Value $15.8k 30,086 shares
Last Trade
Feb 02, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$26.8k 785 shares
$34.09
$0.52
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Chief Financial Officer
Holding Value $16.2k 30,871 shares
Last Trade
Jan 30, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$20k 601 shares
$33.21
$0.52
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Chief Financial Officer
Holding Value $16.5k 31,472 shares
Last Trade
Jan 05, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$21.5k 734 shares
$29.26
$0.52
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Chief Financial Officer
Holding Value $16.9k 32,206 shares
Last Trade
Dec 19, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$13.8k 461 shares
$30.03
$0.52
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Chief Financial Officer
Holding Value $17.2k 32,667 shares
Last Trade
Feb 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$379k 8,000 shares
$47.39
$0.52
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Chief Financial Officer
Holding Value $13k 24,667 shares
Last Trade
Feb 02, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$36.2k 805 shares
$45.03
$0.52
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Chief Financial Officer
Holding Value $13.4k 25,472 shares
Last Trade
Jan 31, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$28.8k 626 shares
$45.94
$0.52
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Chief Financial Officer
Holding Value $13.7k 26,098 shares
Last Trade
Jan 07, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$13.3k 263 shares
$50.63
$0.52
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Chief Financial Officer
Holding Value $13.8k 26,361 shares
Last Trade
Jan 05, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$37.4k 738 shares
$50.69
$0.52
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Chief Financial Officer
Holding Value $14.2k 27,099 shares
Last Trade
Dec 20, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$25.9k 467 shares
$55.42
$0.52
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Chief Financial Officer
Holding Value $14.5k 27,566 shares
Last Trade
Feb 02, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$439k 8,900 shares
$49.32
$0.52
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Chief Financial Officer
Holding Value $9.8k 18,666 shares
Last Trade
Jan 29, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$29.7k 637 shares
$46.67
$0.52
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Chief Financial Officer
Holding Value $7.51k 14,303 shares
Last Trade
Jan 07, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$12.1k 237 shares
$50.97
$0.52

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up